49.05
price up icon1.53%   0.74
after-market 시간 외 거래: 49.49 0.44 +0.90%
loading

왜 Sanofi Adr (SNY) 주가가 하락하고 있습니까?

2025-05-30 거래 세션 동안 Sanofi Adr(SNY) 주식이 5.69% 하락한 것을 확인했습니다. 이는 정상적인 변동성이나 다양한 내부 및 외부 요인에 의한 것일 수 있지만, 상황을 적극적으로 모니터링하고 있으며 최대한 빨리 적시에 업데이트를 제공하도록 하겠습니다!
2023-10-27:

Sanofi ADS Stock (SNY) dropped by 19.13% from $53.33 to $43.13 in the trading on Friday October 27, 2023. The reason why SNY stock down today include

  • Third-quarter financial results. Sanofi's earnings were 2.55 euros per share, tumbled 11.5% year over year and were 2% below expectations. Sales slipped 4.1% to 11.96 billion euros, or about $12.33 billion. Analysts expected a stronger 12.48 billion euros.
  • Lower profit outlook: Sanofi expects its earnings per share to drop slightly in 2024, due to increased investment in research and development. The company has also abandoned its target of a 32% operating margin in 2025, in order to focus on long-term profitability.
  • Spinout of its consumer care unit: Sanofi is considering spinning off its consumer health unit into a separate company as early as the end of next year. The unit, which sells over-the-counter pain relievers and allergy medications like Doliprane and Allegra, accounts for just over 10% of Sanofi's total sales. The spinoff would likely be done through a listing on the Paris stock exchange.
$111.73
price up icon 0.78%
drug_manufacturers_general PFE
$25.04
price up icon 3.30%
$290.52
price up icon 4.05%
drug_manufacturers_general MRK
$81.81
price up icon 3.35%
drug_manufacturers_general NVS
$123.10
price up icon 1.73%
자본화:     |  볼륨(24시간):